Rationale and study design of a randomized controlled trial for development of a treatment strategy for chronic kidney disease–mineral and bone disorder by multilateral mechanism of etelcalcetide hydrochloride (the DUET study)

Rationale and study design of a randomized controlled trial for development of a treatment strategy for chronic kidney disease–mineral and bone disorder by multilateral mechanism of etelcalcetide hydrochloride (the DUET study)

Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in advanced chronic kidney disease (CKD). The aims of this study are to clarify the efficacy of etelcalcetide, a novel-approved intravenous calcimimetic, for evaluating the optimal therapy for etelcalcetide-induced hyp...

Full description

Bibliographic Details
Main Authors: Sawako Kato, Masato Tsuboi, Masahiko Ando, Yuya Itano, Shoichi Maruyama
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Renal Replacement Therapy
Subjects:
Calciprotein particles
Clinical trial
Etelcalcetide
Hemodialysis
Secondary hyperparathyroidism
Online Access:http://link.springer.com/article/10.1186/s41100-019-0236-5

Internet

http://link.springer.com/article/10.1186/s41100-019-0236-5

Similar Items